This is the authors' abstract. We don't add key points for this paper.
The study evaluates the performance of the DigitMI 930 PET/CT system, featuring detector modules with a 1:1:1 coupling of the scintillation crystal, the photosensor, and the electronic readout channel, in adherence to the NEMA NU 2-2018 standard. Moreover, brain and whole-body images were used to assess image quality. The radial, tangential, and axial resolutions at a radial offset of 1 cm were 3.9, 3.9, and 3.7 mm, respectively. The average sensitivity was measured at 16.2 cps/kBq. The peak noise-equivalent count rate was calculated as 412.5 kcps at 34.5 kBq/mL. At an activity concentration of 5.3 kBq/mL, the scatter fraction was 37.5%, and the time-of-flight (TOF) resolution was 248.6 ps. The contrast recovery coefficient ranged from 70.6 to 87.7% with TOF reconstruction. Despite increased noise in shorter whole-body scans, critical lesions remained identifiable at 20-second durations per bed position. The DigitMI 930 PET/CT system demonstrates a strong overall performance, particularly noteworthy for its low spatial resolution to crystal size ratio in comparison to other clinical PET systems. Moreover, the clinical studies indicate that the DigitMI 930 PET/CT system is capable of generating high-quality clinical images with high sensitivity for detecting small lesions, even at low injection doses or short scanning times.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: